TY - JOUR
T1 - The effectiveness of malaria camps as part of the malaria control program in Odisha, India
AU - Ompad, Danielle C.
AU - Padhan, Timir K.
AU - Kessler, Anne
AU - Tozan, Yesim
AU - Jones, Abbey M.
AU - van Eijk, Anna Maria
AU - Sullivan, Steven A.
AU - Haque, Mohammed A.
AU - Pradhan, Madan Mohan
AU - Mohanty, Sanjib
AU - Carlton, Jane M.
AU - Sahu, Praveen K.
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Durgama Anchalare Malaria Nirakaran (DAMaN) is a multi-component malaria intervention for hard-to-reach villages in Odisha, India. The main component, malaria camps (MCs), consists of mass screening, treatment, education, and intensified vector control. We evaluated MC effectiveness using a quasi-experimental cluster-assigned stepped-wedge study with a pretest–posttest control group in 15 villages: six immediate (Arm A), six delayed (Arm B), and three previous interventions (Arm C). The primary outcome was PCR + Plasmodium infection prevalence. The time (i.e., baseline vs. follow-up 3) x study arm interaction term shows that there were statistically significant lower odds of PCR + Plasmodium infection in Arm A (AOR = 0.36, 95% CI = 0.17, 0.74) but not Arm C as compared to Arm B at the third follow-up. The cost per person ranged between US$3–8, the cost per tested US$4–9, and the cost per treated US$82–1,614, per camp round. These results suggest that the DAMaN intervention is a promising and financially feasible approach for malaria control.
AB - Durgama Anchalare Malaria Nirakaran (DAMaN) is a multi-component malaria intervention for hard-to-reach villages in Odisha, India. The main component, malaria camps (MCs), consists of mass screening, treatment, education, and intensified vector control. We evaluated MC effectiveness using a quasi-experimental cluster-assigned stepped-wedge study with a pretest–posttest control group in 15 villages: six immediate (Arm A), six delayed (Arm B), and three previous interventions (Arm C). The primary outcome was PCR + Plasmodium infection prevalence. The time (i.e., baseline vs. follow-up 3) x study arm interaction term shows that there were statistically significant lower odds of PCR + Plasmodium infection in Arm A (AOR = 0.36, 95% CI = 0.17, 0.74) but not Arm C as compared to Arm B at the third follow-up. The cost per person ranged between US$3–8, the cost per tested US$4–9, and the cost per treated US$82–1,614, per camp round. These results suggest that the DAMaN intervention is a promising and financially feasible approach for malaria control.
UR - http://www.scopus.com/inward/record.url?scp=85180732567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85180732567&partnerID=8YFLogxK
U2 - 10.1038/s41598-023-46220-x
DO - 10.1038/s41598-023-46220-x
M3 - Article
C2 - 38155156
AN - SCOPUS:85180732567
SN - 2045-2322
VL - 13
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 22998
ER -